Curaleaf (OTCMKTS:CURLF) Shares Gap Down – What’s Next?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) gapped down prior to trading on Wednesday . The stock had previously closed at $2.72, but opened at $2.62. Curaleaf shares last traded at $2.6680, with a volume of 14,037 shares trading hands.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on CURLF. Zacks Research upgraded Curaleaf from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 1st. Atb Cap Markets upgraded shares of Curaleaf from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 2nd. Alliance Global Partners reaffirmed a “buy” rating on shares of Curaleaf in a research note on Monday, December 22nd. Canaccord Genuity Group raised shares of Curaleaf to a “strong-buy” rating in a research note on Thursday, October 9th. Finally, ATB Capital raised shares of Curaleaf to an “outperform” rating in a report on Tuesday, December 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Buy”.

Curaleaf Price Performance

The company has a debt-to-equity ratio of 0.96, a current ratio of 1.47 and a quick ratio of 0.71. The firm has a market capitalization of $1.80 billion, a P/E ratio of -8.31 and a beta of 0.73. The firm’s 50 day simple moving average is $2.66 and its two-hundred day simple moving average is $2.46.

Curaleaf (OTCMKTS:CURLF) last announced its earnings results on Wednesday, November 5th. The company reported ($0.06) EPS for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.01. Curaleaf had a negative net margin of 19.50% and a negative return on equity of 15.57%. As a group, analysts predict that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.